Document is current

Any future updates will be listed below

Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials

Crossref DOI link: https://doi.org/10.1007/s40744-021-00415-8

Published Online: 2022-01-06

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark